110 related articles for article (PubMed ID: 22267869)
1. Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.
Thompson KL; Haskins K; Rosenzweig BA; Stewart S; Zhang J; Peters D; Knapton A; Rouse R; Mans D; Colatsky T
Int J Toxicol; 2012; 31(1):14-24. PubMed ID: 22267869
[TBL] [Abstract][Full Text] [Related]
2. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.
Thompson KL; Zhang J; Stewart S; Rosenzweig BA; Shea K; Mans D; Colatsky T
Toxicol Lett; 2012 Sep; 213(2):285-91. PubMed ID: 22828012
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers to monitor drug-induced phospholipidosis.
Baronas ET; Lee JW; Alden C; Hsieh FY
Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
[TBL] [Abstract][Full Text] [Related]
4. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.
Liu N; Tengstrand EA; Chourb L; Hsieh FY
Toxicol Appl Pharmacol; 2014 Sep; 279(3):467-476. PubMed ID: 24967688
[TBL] [Abstract][Full Text] [Related]
5. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
[TBL] [Abstract][Full Text] [Related]
6. Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosis.
Murali BV; Kurawattimath V; Bhutani P; Onorato J; Naikodi SB; Kole P; Rajanna PK
Bioanalysis; 2020 Aug; 12(15):1049-1059. PubMed ID: 32735140
[No Abstract] [Full Text] [Related]
7. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
[TBL] [Abstract][Full Text] [Related]
8. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats.
Rouse RL; Zhang J; Stewart SR; Rosenzweig BA; Espandiari P; Sadrieh NK
Kidney Int; 2011 Jun; 79(11):1186-97. PubMed ID: 21150870
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
[TBL] [Abstract][Full Text] [Related]
10. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles.
Rabia M; Leuzy V; Soulage C; Durand A; Fourmaux B; Errazuriz-Cerda E; Köffel R; Draeger A; Colosetti P; Jalabert A; Di Filippo M; Villard-Garon A; Bergerot C; Luquain-Costaz C; Moulin P; Rome S; Delton I; Hullin-Matsuda F
Biochimie; 2020 Nov; 178():26-38. PubMed ID: 32659447
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis and urinary biomarker assays reveal activation of tubulointerstitial injury pathways in a rodent model of chronic proteinuria (Doxorubicin nephropathy).
Cianciolo R; Yoon L; Krull D; Stokes A; Rodriguez A; Jordan H; Cooper D; Falls JG; Cullen J; Kimbrough C; Berridge B
Nephron Exp Nephrol; 2013; 124(1-2):1-10. PubMed ID: 24248038
[TBL] [Abstract][Full Text] [Related]
12. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis.
Sakurai T; Kamio K; Sasaki K; Nishimoto T; Yamaguchi JI; Sasaki M; Tsutsumi S
Am J Pathol; 2018 Sep; 188(9):1993-2003. PubMed ID: 29981744
[TBL] [Abstract][Full Text] [Related]
13. Assessing low-dose gentamicin-induced kidney injury in rats by analysis of urine.
Nykjaer A; Schambye H; Pedersen AH; Nielsen H
J Pharmacol Toxicol Methods; 2009; 60(3):316-20. PubMed ID: 19632345
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.
Mortuza GB; Neville WA; Delaney J; Waterfield CJ; Camilleri P
Biochim Biophys Acta; 2003 Mar; 1631(2):136-46. PubMed ID: 12633679
[TBL] [Abstract][Full Text] [Related]
15. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
[TBL] [Abstract][Full Text] [Related]
17. An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats.
Fuchs TC; Mally A; Wool A; Beiman M; Hewitt P
Vet Pathol; 2014 May; 51(3):680-94. PubMed ID: 23912714
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
[TBL] [Abstract][Full Text] [Related]
19. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
[TBL] [Abstract][Full Text] [Related]
20. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
